Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, will release financial results for the quarter ended March 31, 2020 on Tuesday, May 12, 2020. The...
ResMed (NYSE: RMD) (ASX: RMD) today announced that Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the Bank of...
The first Ford-built powered air-purifying respirators, developed in close collaboration with 3M, are on their way to help protect health care workers fighting COVID-19. Since late...
Test has 99 percent specificity and 100 percent sensitivity after 21 days following the onset of symptoms. The U.S. Food and Drug Administration (FDA) has provided Emergency...
The shield provides a barrier between the healthcare professional and patient during intubation and extubation procedures to reduce exposure. NN Inc., a diversified industrial company, announced...
A global medical aesthetic technology leader, has expanded its executive team with the appointment of Chad A. Zaring to the newly-created role of chief commercial officer...
First destination therapy that restores natural heart pumping capacity; potential for more than 200,000 untreated severe heart failure patients per year. FineHeart, a French medical device...
VitalPatch wearable biosensor can monitor for heart-related side effects of Hydroxychloroquine and other treatments. a developer of wearable biosensor technology, was granted Emergency Use Authorization (EUA) status by...
The U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company) Anti-SARS-CoV-2 ELISA (IgG) serology test. Clinical laboratories certified to perform high...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the first quarter...
Q1 2020 revenue decline of 8.1% year-over-year, organic revenue decline of 7.9% Q1 2020 GAAP EPS of $0.07, compared to $0.20 in Q1 2019; non-GAAP EPS...
The nominations follow a successful seed funding led by Sofinnova Partners a biotechnology company developing novel therapies for rare dermatological diseases, announced today the appointment of...
Results published in CHEST Journal demonstrate benefits of using dynamic measures to guide fluid therapy decisions Baxter International Inc. (NYSE:BAX), a leader in innovative technology for...
Ra Medical Systems, Inc. (NYSE: RMED) announces that it will report first quarter 2020 financial results and provide a business update after market close on Wednesday,...
The temporary special partnership will help Vyaire to rapidly increase the production of critical care ventilators Vyaire Medical and Spirit AeroSystems have collaborated to increase...
Copyright © 2024 Medical Buyer